angiotensin ii has been researched along with ginsenoside rg1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, JM; Mao, N; Shi, XL; Tan, RZ; Wang, L; Wang, SQ; Wei, C | 1 |
| Du, W; Li, X; Xiao, X; Zhang, F; Zhang, S; Zhang, Y; Zhu, M | 1 |
2 other study(ies) available for angiotensin ii and ginsenoside rg1
| Article | Year |
|---|---|
Ginsenoside Rg1 inhibits angiotensin II-induced podocyte autophagy via AMPK/mTOR/PI3K pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Antioxidants; Apoptosis; Autophagy; Cell Line; Down-Regulation; Ginsenosides; Mice; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Podocytes; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association.
Topics: Aconitine; Angiotensin II; Animals; Benzofurans; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Drugs, Chinese Herbal; Ginsenosides; Heart Failure; Isoflavones; Male; Medicine, Chinese Traditional; Quality Control; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2018 |